These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32102572)

  • 1. The use of biologics in the treatment of autoimmune liver disease.
    Chang C; Tanaka A; Bowlus C; Gershwin ME
    Expert Opin Investig Drugs; 2020 Apr; 29(4):385-398. PubMed ID: 32102572
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement activation in autoimmune liver disease.
    Biewenga M; Farina Sarasqueta A; Tushuizen ME; de Jonge-Muller ESM; van Hoek B; Trouw LA
    Autoimmun Rev; 2020 Jun; 19(6):102534. PubMed ID: 32234403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serum DNase1-activity in patients with autoimmune liver diseases.
    Gatselis NK; Vakrakou AG; Zachou K; Androutsakos T; Azariadis K; Hatzis G; Manoussakis MN; Dalekos GN
    Autoimmunity; 2017 Mar; 50(2):125-132. PubMed ID: 28263100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune liver diseases].
    Fischer HP; Goltz D
    Pathologe; 2020 Sep; 41(5):444-456. PubMed ID: 32749523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.
    Boberg KM; Fausa O; Haaland T; Holter E; Mellbye OJ; Spurkland A; Schrumpf E
    Hepatology; 1996 Jun; 23(6):1369-76. PubMed ID: 8675153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune cholangitis within the spectrum of autoimmune liver disease.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
    Hepatology; 2000 Jun; 31(6):1231-8. PubMed ID: 10827147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic cholestatic diseases.
    Poupon R; Chazouillères O; Poupon RE
    J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent and de novo autoimmune liver diseases.
    Mendes F; Couto CA; Levy C
    Clin Liver Dis; 2011 Nov; 15(4):859-78. PubMed ID: 22032533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of overlap syndromes.
    Bunchorntavakul C; Reddy KR
    Clin Liver Dis; 2015 Feb; 19(1):81-97. PubMed ID: 25454298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research advances in autoimmune liver diseases in 2016].
    Li B; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):100-104. PubMed ID: 28297794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in autoimmune liver diseases.
    Manns MP
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S256-71. PubMed ID: 9407346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
    Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
    J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.
    Sebode M; Weiler-Normann C; Liwinski T; Schramm C
    Front Immunol; 2018; 9():609. PubMed ID: 29636752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune hepatitis and autoimmune cholangitis].
    Dienes HP
    Verh Dtsch Ges Pathol; 2005; 89():155-62. PubMed ID: 18035685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
    Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
    Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap Syndromes.
    Chazouillères O
    Dig Dis; 2015; 33 Suppl 2():181-7. PubMed ID: 26641819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.